Pharma and Biotech
No deals were found in the last 365 days.
No deals were found in the last 365 days.
No director shareholdings found for this company
| Notifier** | Holding | Value* |
|---|---|---|
| Mark H Dixon and Diana Dixon | 76,000,000 | £9,120,000 |
| Mark H Dixon | 50,000,000 | £6,000,000 |
| David Campbell Brierwood | 16,416,813 | £1,970,018 |
| Tyndall Investment Management | 13,165,553 | £1,579,866 |
| Tyndall Investment Management | 13,165,553 | £1,579,866 |
| Seneca Partners Limited | 10,561,405 | £1,267,369 |
| Unicorn Asset Management Limited | 7,894,736 | £947,368 |
| Andrew McBain | 4,301,433 | £516,172 |
| Currency | UK Pounds |
| Share Price | 12.00p |
| Change Today | 0.000p |
| % Change | 0.00 % |
| 52 Week High | 12.50 |
| 52 Week Low | 11.50 |
| Volume | 402,350 |
| Shares Issued | 259.04m |
| Market Cap | £31.08m |
| Value |
|
|---|
| Price Trend |
|
|---|
| Income | ![]() |
|---|
| Growth |
|
|---|
| No dividends found |
| Time | Volume / Share Price |
| 16:17 | 40,000 @ 11.94p |
| 14:35 | 8 @ 12.50p |
| 13:32 | 1,533 @ 11.50p |
| 11:32 | 3,387 @ 11.92p |
| 08:51 | 276,804 @ 11.93p |
You are here: research